Table 1.
Diagnosis | Key Diagnostic Features* |
---|---|
Plexiform neurofibroma (PN) | Neoplastic proliferation of S100+ Schwann cells with wavy nuclear contours, diffusely enlarging and replacing a major nerve trunk. Thickened perineural sheath. Microenvironment consisting of fibroblasts with myxoid/collagenous matrix and infiltrating inflammatory cells (mast cells and other lineages). Well-developed, lattice-like CD34+ fibroblastic network. |
Atypical neurofibromatous neoplasm of uncertain biologic potential (ANNUBP) | Schwann cell neoplasm with at least 2 of 4 features: (1) hypercellularity as defined by nuclear overlap at high magnification; (2) cytologic atypia—enlarged nuclei at least 2-3× > normal, hyperchromasia, pleomorphism with irregular chromatin distribution, and/or multinucleated and ‘bizarre’ forms; (3) loss of neurofibroma architecture as defined by fascicular growth pattern or disruption of lattice like CD34+ fibroblastic network; (4) rare mitoses with a mitotic index >1/50 HPF but <3/10 HPF. |
Malignant peripheral nerve sheath tumor (MPNST) | Features of ANNUBP with mitotic index of 3–9/10 HPF without necrosis (low grade MPNST). MPNST with a mitotic index >10/10 HPF or > 3/10 HPF with necrosis (high grade MPNST). |
*Adapted from Miettinen et al. Human Pathology (2017) 67, 1–10.